Authors: Gulbrandsen, N Wisloff, F Brinch, L Carlson, K Dahl, IM Gimsing, P Hippe, E Hjorth, M Knudsen, LM Lamvik, J Lenhoff, S Lofvenberg, E Nesthus, I Nielsen, JL Turesson, L Westin, J

Citation: N. Gulbrandsen et al., Health-related quality of life in multiple myeloma patients receiving high-dose chemotherapy with autologous blood stem-cell support, MED ONCOL, 18(1), 2001, pp. 65-77

Authors: Lamvik, J Hella, H Liabakk, NB Halaas, O

Citation: J. Lamvik et al., Nonlabeled secondary antibodies augment/maintain the binding of primary, specific antibodies to cell membrane antigens, CYTOMETRY, 45(3), 2001, pp. 187-193

Authors: Lenhoff, S Hjorth, M Holmberg, E Turesson, I Westin, J Nielsen, JL Wisloff, F Brinch, L Carlson, K Carlson, M Dahl, IM Gimsing, P Hippe, E Johnsen, H Lamvik, J Lofvenberg, E Nesthus, I Rodjer, S

Citation: S. Lenhoff et al., Impact on survival of high-dose therapy with autologous stem cell support in patients younger than 60 years with newly diagnosed multiple myeloma: a population-based study, BLOOD, 95(1), 2000, pp. 7-11

Authors: Hjorth-Hansen, H Seidel, C Lamvik, J Borset, M Sundan, A Waage, A

Citation: H. Hjorth-hansen et al., Elevated serum concentrations of hepatocyte growth factor in acute myelocytic leukaemia, EUR J HAEMA, 62(2), 1999, pp. 129-134